CYP3A4 and gastrointestinal stromal tumor: After multiple oral doses of 400 mg imatinib in GIST patients, accumulation of the drug occurred; the simulations indicated that only 20% of the assigned CYP3A4-mediated metabolism (40%) remained at a steady state due to autoinhibition of this pathway (Figure 1).